Milk of Magnesia USP Recalled for Microbial Contamination
Plastikon Healthcare LLC is recalling Milk of Magnesia USP (2400 mg/30 mL) distributed in Indiana due to microbial contamination in this non-sterile product. The FDA classified this as a Class I recall.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This is an FDA Class I recall, the highest priority pharmaceutical classification, which requires a minimum severity score of 4 per the rubric rules. Class I recalls are issued for the most serious safety issues in drug products.
Plain-English summary
Plastikon Healthcare LLC is recalling Milk of Magnesia USP (Magnesium Hydroxide), 2400 mg/30 mL, distributed for institutional use. The recall affects 14,100 unit-dose cups distributed in Indiana for further distribution throughout the United States.
The FDA classified this as a Class I recall due to microbial contamination in the non-sterile product formulation. Class I recalls represent the most serious type of pharmaceutical safety action.
Institutions and distributors that received product bearing lot numbers 20024A or 20025A with expiration date March 2022 are affected. Affected parties should immediately stop use and distribution of these lots.
For more information and instructions on handling affected product, contact the distributor Major Pharmaceuticals (Livonia, MI) or the manufacturer Plastikon Healthcare LLC.
The recalled product
- Product
- MILK OF MAGNESIA USP, (Magnesium Hydroxide), 2400 mg/30 mL, 30 mL cup, packaged in 10 cups per tray, 10 trays per carton, For Institutional Use Only, Distributed by Major Pharmaceuticals, Livonia, MI 48152, NDC 0904-6846-73.
- Manufacturer
- Plastikon Healthcare LLC
- Category
- Drug
- Hazard
- microbial-contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot: 20024A
- 20025A
- EXP Mar 2022
Distribution
Distribution scope not specified by the agency.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27